Bond Chemical Industries
Pharmaceutical manufacturer and distributor in Nigeria with WHO/NAFDAC cGMP–aligned facilities, integrated quality control and R&D laboratories, and a product portfolio spanning antimalarials, antibiotics, analgesics, vitamins, antihypertensives and specialty medicines (including subsidised hydroxyurea for sickle cell disease). The company operates automated production lines, climate-controlled warehousing and a national distribution network, and describes involvement in vaccine platform R&D and public health outreach.
Industries
Nr. of Employees
medium (51-250)
Bond Chemical Industries
Head Office: Plot 20-26, Adesakin Layout, Asaba, Awe, P.O. Box 878, Oyo State, Nigeria. Lagos Office: Bond House, 22A Alafia Street, Off Isolo Road, Mushin, P.O. Box 618, Yaba, Lagos State, Nigeria.
Products
Artemether / Lumefantrine formulation (antimalarial)
Artemether/lumefantrine fixed-dose combination used for treatment of uncomplicated Plasmodium falciparum malaria.
Dihydroartemisinin / Piperaquine formulation (antimalarial)
Dihydroartemisinin/piperaquine fixed-dose combination for treatment of Plasmodium falciparum infection.
Hydroxyurea (specialty product for sickle cell management)
Oral hydroxyurea formulations provided for management of sickle cell disorder.
Omeprazole (anti-ulcer agent)
Omeprazole 20 mg proton pump inhibitor for treatment of GERD and gastric acid-related conditions.
Artemether / Lumefantrine formulation (antimalarial)
Artemether/lumefantrine fixed-dose combination used for treatment of uncomplicated Plasmodium falciparum malaria.
Dihydroartemisinin / Piperaquine formulation (antimalarial)
Dihydroartemisinin/piperaquine fixed-dose combination for treatment of Plasmodium falciparum infection.
Hydroxyurea (specialty product for sickle cell management)
Oral hydroxyurea formulations provided for management of sickle cell disorder.
Omeprazole (anti-ulcer agent)
Omeprazole 20 mg proton pump inhibitor for treatment of GERD and gastric acid-related conditions.
Services
On-site manufacturing of solid and liquid dosage forms under WHO/NAFDAC cGMP conditions using automated production lines.
National distribution network with depots, climate-controlled warehousing and fleet management to support product availability across Nigeria and West Africa.
Regulatory documentation, product registration and pharmacovigilance activities aligned with national regulator requirements and international quality expectations.
On-site manufacturing of solid and liquid dosage forms under WHO/NAFDAC cGMP conditions using automated production lines.
National distribution network with depots, climate-controlled warehousing and fleet management to support product availability across Nigeria and West Africa.
Regulatory documentation, product registration and pharmacovigilance activities aligned with national regulator requirements and international quality expectations.
Expertise Areas
- Pharmaceutical manufacturing (solid and liquid dosage forms)
- Quality control and analytical testing
- Formulation development and pilot-scale scale-up
- Vaccine R&D (mRNA and recombinant protein platforms)
Key Technologies
- High-performance liquid chromatography (HPLC)
- Gas chromatography (GC)
- UV-Vis spectrophotometry
- Dissolution testing
News & Updates
Report on NAPharm Lifetime Achievement Awards recognising industry leaders for contributions to local manufacturing, GMP excellence, supply chain resilience and workforce development.
Announcement and program for World Heart Day community screening events including free blood pressure, BMI and basic cholesterol checks and community education (locations: Awe & Lagos).
News item describing engagement on initiatives to stimulate local manufacturing and a featured summary of a next‑gen vaccine platform (mRNA + recombinant) covering antigen design, LNP delivery and parallel expression systems.
Report on NAPharm Lifetime Achievement Awards recognising industry leaders for contributions to local manufacturing, GMP excellence, supply chain resilience and workforce development.
Announcement and program for World Heart Day community screening events including free blood pressure, BMI and basic cholesterol checks and community education (locations: Awe & Lagos).
News item describing engagement on initiatives to stimulate local manufacturing and a featured summary of a next‑gen vaccine platform (mRNA + recombinant) covering antigen design, LNP delivery and parallel expression systems.